Alphatec sells tools used in spine surgery, and the bull case hinges on more surgeons choosing its approach as it rolls out new tech like robotics and a more connected “full system” for the operating room. The catch is that it’s still proving it can turn this focus into steady profits while facing big rivals, shifting treatment trends, and strict medical-device rules.Read more
Alphatec is pushing a less invasive, tech-heavy approach to spine surgery that could win over more surgeons and hospitals, especially as demand shifts toward faster recovery care. The big question is whether it can keep pricing power and avoid regulatory and reimbursement pressure while it tries to turn past losses into lasting profitability.Read more
Alphatec’s spine surgery tech is growing fast, but hospitals and insurers are pushing harder to cut costs, which could make it tougher to keep prices and profits rising. See how tighter rules, slower product approvals, and more powerful hospital buyers could reshape the company’s path—and what signs of momentum might prove that worry wrong.Read more
No trending discussion available.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
